Role of Echocardiography in Pulmonary Embolism
Echocardiographic Parameters in Predicting Outcome in Patients With Intermediate - Risk Pulmonary Embolism
1 other identifier
observational
30
0 countries
N/A
Brief Summary
- 1.To analyze the diagnostic and prognostic value of echocardiographic parameters.
- 2.Prediction of APE-related 30-day mortality and adverse out comes.
- 3.The need for rescue thrombolysis in initially normotensive Acute pulmonary embolism (APE) patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2019
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 9, 2019
CompletedFirst Posted
Study publicly available on registry
July 16, 2019
CompletedStudy Start
First participant enrolled
August 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2020
CompletedJuly 16, 2019
July 1, 2019
1 year
July 9, 2019
July 11, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
the need for rescue thrombolysis in initially normotensive Acute pulmonary embolism patients.
analyses the diagnostic and prognostic value of a new echocardiographic parameter, TRPG/ TAPSE, for prediction of APE-related 30-day death or the need for rescue thrombolysis in initially normotensive Acute pulmonary embolism patients.
one month
Interventions
Echocardiographic parameters: Tricuspid annulus plane systolic excursion (TAPSE) Tricuspid regurgitation peak gradient (TRPG)
Eligibility Criteria
patients diagnosed with pulmonary embolism confirmed by contrast-enhanced multidetector computed tomography (MDCT) when thrombo-emboli were visualized
You may qualify if:
- Age \>18 and \<70 years.
- Patients with intermediate- risk pulmonary embolism will be
- hemodynamically stable at admission with systolic blood pressure
- mmHg and without signs of peripheral hypoperfusion.
- \- elevated cardiac biomarkers levels (particularly, a positive cardiac troponin test
You may not qualify if:
- Age \<18 years.
- Patients diagnosed with chronic thromboembolic hypertension.
- Patients with valvular heart diseases.
- Patients with lung cancer.
- Acute massive pulmonary embolism.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Bernard S, Namasivayam M, Dudzinski DM. Reflections on Echocardiography in Pulmonary Embolism-Literally and Figuratively. J Am Soc Echocardiogr. 2019 Jul;32(7):807-810. doi: 10.1016/j.echo.2019.05.007. No abstract available.
PMID: 31272591BACKGROUNDKanar BG, Sahin A, Gol G, Ogur E, Kavas M, Atas H, Mutlu B. Timing and magnitude of regional right ventricular function and their relationship with early hospital mortality in patients with acute pulmonary embolism. Anatol J Cardiol. 2019 Jun;22(1):26-32. doi: 10.14744/AnatolJCardiol.2019.38906.
PMID: 31264657BACKGROUNDKanar BG, Gol G, Ogur E, Kavas M, Atas H, Mutlu B. Assessment of right ventricular function and relation to mortality after acute pulmonary embolism: A speckle tracking echocardiography-based study. Echocardiography. 2019 Jul;36(7):1298-1305. doi: 10.1111/echo.14398. Epub 2019 Jun 11.
PMID: 31184782BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
July 9, 2019
First Posted
July 16, 2019
Study Start
August 1, 2019
Primary Completion
August 1, 2020
Study Completion
September 1, 2020
Last Updated
July 16, 2019
Record last verified: 2019-07